PureTech Health PTCHF
OTC PTCHF
$1.48 -0.03 (-1.99%)
At close: Oct 14, 2026 · 4:00 PM EDT

PureTech Health (PTCHF) EBIT Margin (2025)

Updated

PureTech Health's EBIT Margin was -2114.77% in the year ended Dec 31, 2025, up 1039.23 percentage points from -3154.00% a year earlier.

Analysis

PureTech Health (PTCHF) EBIT Margin (2025) Analysis & Trends

From the year ended Dec 31, 2018 onward, PureTech Health has reported EBIT Margin for 8 years.

  • EBIT Margin shows a five-year change of -681.71 percentage points (years ended Dec 2020 to Dec 2025).
  • The figure for the year ended Dec 31, 2025 marks the highest annual EBIT Margin since the year ended Dec 31, 2021.
  • Per Business Quant data, EBIT Margin in earlier years was -3154.00% in the year ended Dec 31, 2024 (+16339.20 pp), -19493.20% in the year ended Dec 31, 2023 (-10028.75 pp), -9464.45% in the year ended Dec 31, 2022 (-7958.47 pp) and -1505.98% in the year ended Dec 31, 2021 (-72.93 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 PureTech Health 35.77 Mn -1.44 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -2,369.48%
API Access

PureTech Health EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=PTCHF&period=max&api_key=YOUR_API_KEY